Literature DB >> 824157

Liver microsomal drug-metabolizing enzyme system: functional components and their properties.

A Y Lu.   

Abstract

The liver microsomal drug-metabolizing enzyme system consists of two protein components, cytochrome P-450 and NADPH-cytochrome c reductase, and a lipid, phosphatidylcholine. Cytochrome P-450 serves as the binding site for oxygen and substrate while the reductase acts as an electron carrier shuttling electrons from NADPH to cytochrome P-450. The phospholipid facilitates the transfer of electrons from NADPH-cytochrome c reductase to cytochrome P-450 but itself is not an electron carrier. Different cytochromes P-450 and P-448 have been purified; the spectral, catalytic, and immunological properties as well as the molecular weight (determined by SDS-gel electrophoresis) of all these hemeproteins differ from one another. The presence of multiple cytochrome P-450s may explain the species, strain, age, tissue, and sex differences as well as the effect of inducers and nutritional status in mammlian drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 824157

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  7 in total

1.  Effect of pyrethroid insecticides and N-(3,5-dichlorophenyl) dicarboximide fungicides on microsomal drug-metabolizing enzymes in the Japanese quail (Coturnix coturnix).

Authors:  J L Riviere; J Bach; G Grolleau
Journal:  Bull Environ Contam Toxicol       Date:  1983-10       Impact factor: 2.151

2.  Metabolic activation of drugs in mutagenicity tests in vitro.

Authors:  M B Roberfroid
Journal:  Arch Toxicol       Date:  1980-11       Impact factor: 5.153

3.  Expression of aromatic polycyclic hydrocarbon-induced monooxygenase (aryl hydrocarbon hydroxylase) in man x mouse hybrids is associated with human chromosome 2.

Authors:  F J Wiebel; P Hlavica; K H Grzeschik
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  Relationship between lipid composition and drug metabolizing capacity of human liver.

Authors:  M J Savolainen; A J Arranto; I E Hassinen; P V Luoma; R O Pelkonen; E A Sotaniemi
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Modulation of hepatic cytochrome P-450 and DT-diaphorase by oral and sub-cutaneous administration of the pro-oxidant fungicide dichlone (2,3-dichloro-1,4-naphthoquinone).

Authors:  A J Elliott; R S Pardini
Journal:  Bull Environ Contam Toxicol       Date:  1988-08       Impact factor: 2.151

6.  Monooxygenase and UDP-glucuronyltransferase activities in established cell culture.

Authors:  F J Wiebel; J Singh
Journal:  Arch Toxicol       Date:  1980-03       Impact factor: 5.153

7.  Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers.

Authors:  Anne Elfgen; Michelle Hupert; Kevin Bochinsky; Markus Tusche; Estibaliz González de San Román Martin; Ian Gering; Silvia Sacchi; Loredano Pollegioni; Pitter F Huesgen; Rudolf Hartmann; Beatrix Santiago-Schübel; Janine Kutzsche; Dieter Willbold
Journal:  Sci Rep       Date:  2019-04-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.